Status:
UNKNOWN
Analysis of Sublingual Glycocalyx Damage at ICU Admission to Predict Risk of Death
Lead Sponsor:
University Hospital Muenster
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this observative, prospective study is to evaluate if and to what extent glycocalyx damage/microcirculation data at admission in the ICU as well as during ICU stay can be predictive of mort...
Eligibility Criteria
Inclusion
- ICU patients admitted to the ICU with the clinican suspicion of sepsis/septic shock.
Exclusion
- Underage persons, pregnant women, patients with inflammation or trauma of sublingual mucosa.
Key Trial Info
Start Date :
April 15 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03847493
Start Date
April 15 2019
End Date
December 31 2023
Last Update
November 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitiy Hospital Muenster
Münster, Germany, 48149